
No. of Pages: 116 | Report Code: TIPRE00028814 | Category: Life Sciences
No. of Pages: 116 | Report Code: TIPRE00028814 | Category: Life Sciences
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Middle East and Africa Carbapenem-based Antibiotics Market – By Type
1.3.2 Middle East and Africa Carbapenem-based Antibiotics Market – By Indication
1.3.3 Middle East and Africa Carbapenem-based Antibiotics Market – By Distribution Channel
1.3.4 Middle East and Africa Carbapenem-based Antibiotics Market – By Country
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4.1 Overview
4.2 PEST Analysis
4.2.1 Middle East and Africa– PEST Analysis
4.3 Expert Opinions
5.1 Drivers
5.1.1 Rising Prevalence of Gram-Negative Bacterial Infections
5.1.2 Increasing Production of Generic Drugs
5.2 Market Restraints
5.2.1 Tedious and Expensive Process of Antibiotic Development
5.3 Market Opportunities
5.3.1 Private and Public Partnerships
5.4 Future Trends
5.4.1 Strategic Advancement for New Antibiotic Identification
5.5 Impact Analysis
6.1 Middle East and Africa Carbapenem-based Antibiotics Market Revenue Forecast and Analysis
7.1 Overview
7.2 Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)
7.3 Meropenem
7.3.1 Overview
7.3.2 Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Doripenem
7.4.1 Overview
7.4.2 Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Imipenem
7.5.1 Overview
7.5.2 Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Tebipenem
7.6.1 Overview
7.6.2 Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
7.7 Others
7.7.1 Overview
7.7.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.1 Overview
8.2 Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)
8.3 Bacterial Meningitis
8.3.1 Overview
8.3.2 Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Acute Pelvic Infections
8.4.1 Overview
8.4.2 Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Respiratory Tract Infections
8.5.1 Overview
8.5.2 Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Intra-abdominal Infections
8.6.1 Overview
8.6.2 Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.7 Urinary Tract Infections
8.7.1 Overview
8.7.2 Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
8.8 Others
8.8.1 Overview
8.8.2 Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9.1 Overview
9.2 Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)
9.3 Retail Pharmacies
9.3.1 Overview
9.3.2 Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9.4 Online Pharmacies
9.4.1 Overview
9.4.2 Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
9.5 Hospital Pharmacies
9.5.1 Overview
9.5.2 Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
10.1 Middle East and Africa: Carbapenem-based Antibiotics Market
10.1.1 Overview
10.1.2 Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.3 Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.4 Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ Million)
10.1.5 Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ Million)
10.1.6 Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
10.1.6.1 UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.1 UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.1.2 UAE: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.1.3 UAE: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.1.4 UAE: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.1.6.2 Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.1 Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.2.2 Saudi Arabia: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.2.3 Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.2.4 Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.1.6.3 South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.1 South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.3.2 South Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.3.3 South Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.3.4 South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
10.1.6.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.4.1 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
10.1.6.4.2 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type, 2019–2028 (US$ ‘Million)
10.1.6.4.3 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication, 2019–2028 (US$ ‘Million)
10.1.6.4.4 Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel, 2019–2028 (US$ ‘Million)
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.3 Inorganic Developments
11.3.1 Overview
12.1 ACS Dobfar S.p.A
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Gland Pharma Limited
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Merck & Co., Inc.
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Savior Lifetec
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Pfizer Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Spero Therapeutics
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13.1 About The Insight Partners
13.2 Glossary of Terms
Table 1. Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 2. Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ Million)
Table 3. Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ Million)
Table 4. UAE: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 5. UAE: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 6. UAE: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 7. Saudi Arabia: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 8. Saudi Arabia: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 9. Saudi Arabia: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 10. South Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 11. South Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 12. South Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 13. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Type – Revenue and Forecast to 2028 (US$ ‘Million)
Table 14. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Indication – Revenue and Forecast to 2028 (US$ ‘Million)
Table 15. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market, by Distribution Channel – Revenue and Forecast to 2028 (US$ ‘Million)
Table 16. Organic Developments in the Carbapenem-based Antibiotics Market
Table 17. Inorganic Developments in the Carbapenem-based Antibiotics Market
Table 18. Glossary of Terms, Carbapenem-based Antibiotics Market
Figure 1. Carbapenem-based Antibiotics Market Segmentation
Figure 2. Carbapenem-based Antibiotics Segmentation, By Country
Figure 3. Middle East and Africa Carbapenem-based Antibiotics Market Overview
Figure 4. The Others Segment Held Largest Share of Type Segment in Carbapenem-based Antibiotics Market
Figure 5. Middle East and Africa Carbapenem-based Antibiotics Market- Leading Country Markets (US$ Million)
Figure 6. Middle East and Africa PEST Analysis
Figure 7. Carbapenem-based Antibiotics Market Impact Analysis of Driver and Restraints
Figure 8. Middle East and Africa Carbapenem-based Antibiotics Market – Revenue Forecast and Analysis – 2021- 2028
Figure 9. Carbapenem-based Antibiotics Market Revenue Share, by Type (2021 and 2028)
Figure 10. Meropenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Doripenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Imipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Tebipenem: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Carbapenem-based Antibiotics Market, by Indication, 2021 and 2028 (%)
Figure 16. Bacterial Meningitis: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Acute Pelvic Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Respiratory Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Intra-abdominal Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Urinary Tract Infections: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Others: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Carbapenem-based Antibiotics Market, by Distribution Channel, 2021 and 2028 (%)
Figure 23. Retail Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Online Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 25. Hospital Pharmacies: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Middle East and Africa: Carbapenem-based Antibiotics Market, by Key Country – Revenue (2021) (US$ ‘Million)
Figure 27. Middle East and Africa: Carbapenem-based Antibiotics Market Revenue and Forecast to 2028 (US$ ‘Million)
Figure 28. Middle East and Africa: Carbapenem-based Antibiotics Market, by Country, 2021 & 2028 (%)
Figure 29. UAE: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 30. Saudi Arabia: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 31. South Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)
Figure 32. Rest of Middle East and Africa: Carbapenem-based Antibiotics Market – Revenue and Forecast to 2028 (US$ ‘Million)